Natural product-based therapy for mitigating human preterm birth: Ankaflavin inhibits preterm birth via down regulation of its target gene, 7/June/2015, 11.26 pm

Natural product-based therapy for mitigating human preterm birth: Ankaflavin inhibits preterm birth via down regulation of its target gene, 7/June/2015, 11.26 pm

Natural product-based therapy for mitigating human preterm birth: Ankaflavin inhibits preterm birth via down regulation of its target gene, 7/June/2015, 11.26 pm 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Natural product-based therapy for mitigating human preterm birth:  Ankaflavin inhibits preterm birth via down regulation of its target gene, 7/June/2015, 11.26 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: 

This suggests, for the first time, that Icariin, by increasing the expression of its target gene, it may inhibit preterm birth.  Thus, pharmacological formulations encompassing “Ankaflavin or its analogues may be used to inhibit preterm birth.

Undisclosed information: How Ankaflavin inhibits preterm birth

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation